Literature DB >> 32454690

Establishment and Escalation of an Amino Acid Stacked Repressible Release Embedded System Using Quality by Design.

Vijay Sharma1, Lalit Singh1, Navneet Verma2.   

Abstract

OBJECTIVES: The traditional approach of developing a new delivery system is an exhaustive task and requires a number of resources like manpower, money, material, and time. To overcome this problem Quality by Design (QbD) can be utilized to obtain pharmaceutical products of desired (best) quality with minimum use of the above resources as well as determination of the impact of one factor over the desired associated process. The present research is focused on establishing a design for formulating optimized gelatin microspheres using QbD.
MATERIALS AND METHODS: Repressible released embedded microspheres of L-arginine were prepared by performing cross linking of gelatin using glutaraldehyde. Characterization of the formulated embedded microspheres was done based on infrared spectroscopy, scanning electron microscopy, percentage yield, microsphere size, drug entrapment efficiency, and drug release. The impact of concentrations of gelatin and ethyl cellulose was determined over dependent response like percentage yield, microsphere size, and drug entrapment efficiency.
RESULTS: A response surface curve was obtained using a 32 central composite design and the optimized batch was obtained with percentage yield, microsphere size, and drug entrapment efficiency of 89.98, 333.32 mm, and 82.61%, respectively. Validation of the optimized batch was done by formulating four different batches with optimized values of independent response and a comparison of the observed responses with the predicted ones was set up and all these batches were found close to the predicted values and show the validity of the optimized data.
CONCLUSION: The QbD approach is quite efficient to get optimized drug delivery systems of L-arginine without exhaustive study. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  L-arginine; central composite design; characterization of microspheres; gelatin; microspheres

Year:  2018        PMID: 32454690      PMCID: PMC7227980          DOI: 10.4274/tjps.44154

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  13 in total

1.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

2.  Decreased arginine bioavailability and increased serum arginase activity in asthma.

Authors:  Claudia R Morris; Mirjana Poljakovic; Lisa Lavrisha; Lorenzo Machado; Frans A Kuypers; Sidney M Morris
Journal:  Am J Respir Crit Care Med       Date:  2004-04-07       Impact factor: 21.405

3.  Quality by design approach to understand the process of nanosuspension preparation.

Authors:  Sudhir Verma; Yan Lan; Rajeev Gokhale; Diane J Burgess
Journal:  Int J Pharm       Date:  2009-05-14       Impact factor: 5.875

4.  Quality by design: concepts for ANDAs.

Authors:  Robert A Lionberger; Sau Lawrence Lee; Laiming Lee; Andre Raw; Lawrence X Yu
Journal:  AAPS J       Date:  2008-05-09       Impact factor: 4.009

5.  Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties.

Authors:  E Esposito; R Cortesi; C Nastruzzi
Journal:  Biomaterials       Date:  1996-10       Impact factor: 12.479

6.  1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.

Authors:  Nicholas A Peppas
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

7.  Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

Review 8.  New drug delivery systems based on chitosan.

Authors:  Inés Paños; Niuris Acosta; Angeles Heras
Journal:  Curr Drug Discov Technol       Date:  2008-12

9.  In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.

Authors:  Yasunori Sato; Yoshiaki Kawashima; Hirofumi Takeuchi; Hiromitsu Yamamoto
Journal:  Int J Pharm       Date:  2004-05-04       Impact factor: 5.875

10.  Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics.

Authors:  Bhupinder Singh; Sonia Pahuja; Rishi Kapil; Naveen Ahuja
Journal:  Acta Pharm       Date:  2009-03       Impact factor: 2.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.